✦ LIBER ✦

Durability of hbeag seroconversion in chronic hepatitis B patients after lamivudine A-interferon or lamivudine A- interferon combination therapy

✍ Scribed by A.B. Van Nunen; B. Hansen; D. Suh; H. Loehr; H. Fontaine; L. Chemello; B. Song; J. Heathcote; H. Janssen; R.A. de Man; S.W. Schalm

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine vs lamivudine and interferon

✍ C. Yurdaydin; H. Bozkaya; H. Çetinkaya; T. Şahin; D. Karaoğuz; M. Törüner; Ö. Er 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Lamivudine/pegylated interferon alfa-2b

✍ Themistoklis Vassiliadis; Konstantinos Tziomalos; Kalliopi Patsiaoura; Thomas Za 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Comparison of lamivudine monotherapy wit

✍ Z. Karasu; G. Ersoz; U. Akarca; F. Gunsar; R. Vardar; Y. Batur 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Lamivudine and 24 weeks of lamivudine/in

✍ Eugene R Schiff; Jules L Dienstag; Selim Karayalcin; Ian S Grimm; Robert P Perri 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Treatment of HBeAg (−) chronic hepatitis

✍ C. Yurdaydin; H. Bozkaya; H. Çetinkaya; N. Sasmaz; T. Sahin; H. Altin; D. Oguz; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Lamivudine therapy in HBeAg negative chr

✍ Guclu, E.; Batirel, A.; Ince, N. Koc; Ogutlu, A.; Durmaz, Y.; Ozdemir, D.; Geyik 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB